Ignite Creation Date:
2025-12-25 @ 2:42 AM
Ignite Modification Date:
2025-12-26 @ 7:06 PM
Study NCT ID:
NCT05781633
Status:
UNKNOWN
Last Update Posted:
2023-03-23
First Post:
2023-02-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Efficacy and Safety of Eutideron, Etoposide, and Bevacizumab in Patients With Brain Metastases From Breast Cancer.
Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-20
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-20
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-07-20
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-19
First Submit QC Date:
None
Study First Post Date:
2023-03-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-10
Last Update Post Date:
2023-03-23
Last Update Post Date Type:
ACTUAL